Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00548132 · ClinicalTrials.gov registry record · Phase 4
Reducing Catheter-Related Bloodstream Infections in the ICU With a Chlorhexidine-Impregnated Sponge (BIOPATCH)
A Phase 4 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,088
- Enrollment target
NCT00548132: Completed Phase 4 study, sponsored by Washington University School of Medicine.
NCT00548132 is a Phase 4 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 1,088 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (110% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00548132, a Phase 4 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,088 participants
- Enrollment target
Study Summary
We proposed to perform a prospective randomized controlled trial to study the effect of the use of a commercially-available chlorhexidine-impregnated sponge (Biopatch) as part of central venous catheter care on catheter-related bloodstream infections among patients in two Barnes-Jewish Hospital ICUs.
Primary Outcome
The outcome measure is the number of episodes of bloodstream infections (BSI) divided by the catheter days at risk multiplied by 1000 for standardization
Interventions
- DEVICE Chlorhexidine-impregnated foam dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,088 participants |
| Start Date | 2006-02 |
| Est. Completion | 2009-05 |
| Phase | Phase 4 |
What the finished NCT00548132 record still lists
NCT00548132 is an interventional study that assigns participants to a tested intervention. Its 1,088 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (110% higher).
The record links to 0 conditions, and to 1 intervention - of which Chlorhexidine-impregnated foam dressing is the first listed.
NCT00548132 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00548132 about?
NCT00548132 is a clinical study titled "Reducing Catheter-Related Bloodstream Infections in the ICU With a Chlorhexidine-Impregnated Sponge (BIOPATCH)". We proposed to perform a prospective randomized controlled trial to study the effect of the use of a commercially-available chlorhexidine-impregnated sponge (Biopatch) as part of central venous catheter care on catheter-related bloodstream infections among patients in two Barnes-Jewish Hospital ICUs...
What is the current status of trial NCT00548132?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,088 participants. The study started on 2006-02. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00548132?
The interventions under investigation include: Chlorhexidine-impregnated foam dressing (DEVICE).
Who is sponsoring clinical trial NCT00548132?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00548132's enrollment target sits among peer trials
1,088 66th of 2000 higher than 1,935 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06671483 · 1,088 participants · Phase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- NCT07196722 · 1,092 participants · Phase 2
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- NCT03754114 · 1,094 participants · NA
Brain Oxygen Optimization in Severe TBI, Phase 3
- NCT06118983 · 1,094 participants · NA
Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia